Medidata Medidata


A Statement from our Co-Founders and Co-CEOs Glen de Vries and Tarek Sherif

Your Research Brings Hope To Millions of Patients. Our Platform Accelerates it.

Acorn AI is designed to make data liquid across the lifecycle and answer the most important questions.

The Impact of COVID-19 on Clinical Trial Sites

Medidata surveyed over 1,000 sites to see how the COVID-19 pandemic is affecting their ability to start, conduct and complete clinical studies.

Stay informed: Medidata’s customer commitment during COVID-19 (Learn more)

COVID-19 and Clinical Trials: The Medidata Perspective

Release 7.0

As the global impact of COVID-19 increases, Medidata is continuously analyzing its effect on patient study enrollment, the response by world regulatory bodies and which Medidata’s solutions can help address your COVID 19-related challenges.

[SCOPE Webinar] How Five COVID-19 Technology Innovations are Reducing Risk in Clinical Trials

Join our next panel discussion—including live Q&A—exploring how regulators and sponsors have reimagined technology innovations addressing the impact of COVID-19.

Help Us Power Technology That Changes Lives